Intravenous immunoglobulin (IVIG) therapy acts independently of the neonatal Fc-receptor in experimental epidermolysis bullosa acquisita

被引：0
|
作者：
Kasperkiewicz, M. [1 ]
Ishii, N. [1 ]
Hirose, M. [1 ]
Freitag, M. [1 ]
Schmidt, E. [1 ]
Recke, A. [1 ]
Zillikens, D. [1 ]
Ludwig, R. J. [1 ]
机构：
[1] Med Univ Lubeck, Klin Dermatol Allergol & Venerol, D-23538 Lubeck, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2009年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：290 / 290
页数：1
相关论文
共 44 条
  • [31] RETICULOENDOTHELIAL SYSTEM FC-RECEPTOR FUNCTION IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA AFTER TREATMENT WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
    BUDDE, U
    AUCH, D
    NIESE, D
    SCHAFER, G
    RESKE, SN
    SCHMIDT, RE
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1986, 37 (02): : 125 - 129
  • [32] EFFECT OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) THERAPY ON SELECTED PRO-INFLAMMATORY CYTOKINES IN NEONATAL SEPSIS 61
    K N Haque
    L E V Miranda
    C Siqueira
    Pediatric Research, 1997, 41 (5) : 754 - 754
  • [33] Identification of an Fcγ receptor-independent mechanism by which intravenous immunoglobulin (IVIG) ameliorates antiphospholipid antibodies-induced thrombosis.
    Pierangeli, S
    Liu, XW
    Espinola, R
    Harris, EN
    Salmon, J
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S369 - S369
  • [34] ENHANCED FC-RECEPTOR EXPRESSION BY A SUBPOPULATION OF MURINE INTRA-TUMOR MACROPHAGES FOLLOWING INTRAVENOUS CORYNEBACTERIUM-PARVUM THERAPY
    MOORE, K
    MCBRIDE, WH
    BRITISH JOURNAL OF CANCER, 1983, 47 (06) : 797 - 802
  • [35] Effects of intravenous immunoglobulin therapy and Fc gamma receptor polymorphisms on BK virus nephropathy in kidney transplant recipients
    Moon, Jungyeon
    Chang, Youngil
    Shah, Tariq
    Min, David I.
    TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (04)
  • [36] Intravenous immunoglobulin (IVIG) promotes brain repair and improves cognitive outcomes after traumatic brain injury in a Fc?RIIB receptor-dependent manner
    Willis, Emily F.
    Gillespie, Ellen R.
    Guse, Kirsten
    Zuercher, Adrian W.
    Kasermann, Fabian
    Ruitenberg, Marc J.
    Vukovic, Jana
    BRAIN BEHAVIOR AND IMMUNITY, 2023, 109 : 37 - 50
  • [37] Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor
    Gouilleux-Gruart, V.
    Chapel, H.
    Chevret, S.
    Lucas, M.
    Malphettes, M.
    Fieschi, C.
    Patel, S.
    Boutboul, D.
    Marson, M. -N.
    Gerard, L.
    Lee, M.
    Watier, H.
    Oksenhendler, E.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 171 (02): : 186 - 194
  • [38] Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor
    Oksenhendler, E.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 178 : 92 - 93
  • [39] Treatment of peripheral blood mononuclear cells (PBMC) with intravenous immunoglobulin (IVIG) preparations modulates FC receptor expression and inhibits T-cell responses in-vitro
    Long, B. N.
    Carter, C. R.
    Baxter, E.
    Morgan, A.
    Robinson, J. I.
    Savic, S.
    IMMUNOLOGY, 2014, 143 : 135 - 135
  • [40] THE USE OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) DURING SEVERE NEUROTOXICITY AMONG THE RECIPIENTS OF CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) THERAPY
    Mokhtari, Sepideh
    Asquith, Justin
    Bachmeier, Christina
    Faramand, Rawan
    Kim, Youngchul
    Peguero, Edwin
    Sahebjam, Solmaz
    Jain, Michael
    Vogelbaum, Michael
    Davila, Marco
    Forsyth, Peter
    Locke, Frederick
    Aleksandr, Lazaryan
    NEURO-ONCOLOGY, 2020, 22 : 128 - 128
12345